HomeNews

News

News

New Therapy Choices Rising for Throughout Lung Most cancers Subtypes

Editor -
Lung most cancers is a illness that now has numerous therapeutic choices out there, particularly following knowledge learn outs on the 2025 ASCO...
News

The Analysis That Modified It All

Editor -
Karen Cohn is a retired center college particular training trainer who was recognized with follicular lymphoma in July 2020. Atone for all of Karen's...
News

Understanding the Significance of the DESTINY-Breast09 Trial in HER2+ Breast Most cancers

Editor -
Dr. Sara M. Tolaney discusses key takeaways from the DESTINY-Breast09 trial that sufferers with HER2+ superior or metastatic breast most cancers ought to...
News

Breyanzi Exhibits Sturdy Responses in R/R Marginal Zone Lymphoma

Editor -
Breyanzi demonstrated a 95.5% response price amongst in relapsed/refractory marginal zone lymphoma: © inventory.adobe.com.Breyanzi (liso-cel; lisocabtagene maraleucel) demonstrated excessive charges of sturdy responses and...
News

Most cancers Recurrence, Getting Previous the Nervousness

Editor -
Sue McCarthy obtained diagnoses of breast most cancers in 2001 and lung most cancers in 2018. Atone for all of Sue's blogs right here!Can...
1...295296297...672Page 296 of 672

Hot Topics

Load more

Quick Links

Must Read

Popular Articles

© 2024 Cancer Care Portal. All rights reserved.